These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24659663)

  • 1. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
    Uskudar Teke H; Gulbas Z; Bal C
    J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
    Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
    Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
    Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
    Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
    Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
    Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
    Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma.
    Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Zaccari G; Papa G
    Thromb Haemost; 1993 Oct; 70(4):568-72. PubMed ID: 8115979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of some inflammatory markers in patients with lymphoma.
    Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
    Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
    J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis.
    Ueda K; Nakanishi T; Shimizu A; Takubo T; Matsuura N
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):65-9. PubMed ID: 18275676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
    Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
    J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma.
    Malec M; Söderqvist M; Sirsjö A; MacNamara B; Lewin N; Sjöberg J; Björkholm M; Porwit-MacDonald A
    Haematologica; 2004 Jun; 89(6):679-85. PubMed ID: 15194535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine deregulation in hematological malignancies: clinical and biological implications.
    Kurzrock R
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2581-4. PubMed ID: 9815659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
    Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
    Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.